Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

53.93
Delayed Data
As of Jun 28
 +1.44 / +2.74%
Today’s Change
21.05
Today|||52-Week Range
57.00
+12.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues38.5M110.9M160.3M110.3M
 
 
 
 
 
Depreciation And Amortization2.3M2.3M2.3M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses85.0M91.8M116.9M93.9M
 
 
 
 
 
Research And Development77.4M83.9M101.1M82.6M
 
 
 
 
 
Total Operating Expenses87.3M94.1M119.2M96.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-48.8M16.8M41.2M14.0M
 
 
 
 
 
Extraordinary Charge-100.0K-700.0K-4.0M0.00
 
 
 
 
Interest Expense On Debt9.6M9.7M9.9M11.4M
 
 
 
 
 
Other Expenses0.000.0013.0K-1.1M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-57.1M7.4M28.8M3.5M
 
 
 
 
 
Income Taxes-231.0K0.00-2.9M0.00
 
 
 
Net Income-56.9M7.4M25.9M3.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS120.8M121.0M121.3M122.9M
 
 
 
 
 
Shares To Calculate EPS Diluted120.8M123.4M124.0M125.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47$0.06$0.21$0.03
 
 
 
 
 
EPS Diluted-$0.47$0.06$0.21$0.03